Dasatinib
Chemotherapeutic Drug
Earnings Preview: Bristol-Myers 3Q earnings reportMeanwhile, she said investor focus remains on cost savings, sales of four growth drivers - Plavix, Orencia for rheumatoid arthritis, leukemia drug Sprycel and combination HIV drug Atripla - along with some key drugs in development. Those... In this article: Bristol-Myers, Plavix, Revenue, Abilify, Food and Drug Administration, AstraZeneca PLC, Bristol, Ipilimumab, and Otsuka Pharmaceutical Co. |
-
San Francisco Chronicle | October 22, 2009
Drugmakers mostly post higher profits, muted sales
It had sales of $5.49 billion, up nearly 5 percent. Abilify, Orencia for rheumatoid arthritis, leukemia drug Sprycel and hepatitis B drug Baraclude all had double-digit sales increases. Blood thinner Plavix, the world's No. 2 drug, had...
In this article: Merck & Co., Schering-Plough Corp, Revenue, Bristol-Myers, Novartis AG, Januvia, Allergy, U.S., Recession, and Tax
-
MedicineNet | November 10, 2009
Kareem Abdul-Jabbar Has CML Form of Leukemia
...people with leukemia can benefit from the drugs, and said that he's serving as a spokesman to raise awareness of all forms of leukemia. Deininger serves as a consultant for Novartis as well as for Bristol-Myers Squibb, the maker of Sprycel.
In this article: Leukemia, Kareem Abdul-Jabbar, Tasigna, Sprycel, Novartis, Bruno Kirby, Chronic myelogenous leukemia, Philadelphia chromosome, and Oregon Health & Science University
-
Seeking Alpha | November 03, 2009
Cramer's Mad Money - Agnico Eagle's Golden Disappointment (11/2/09)
...patent in 2012. Currently Bristol Myers has a Phase III drug for metastic melanoma, Erbitux for colorectal, head and neck cancer, Sprycel for Leukemia, Ixempra for breast cancer and Taxol for breast, lung and ovarian cancer. Sprycel is the...
In this article: Jim Cramer, Pfizer, Bristol Myers, Jarden, Stanley Works, Black & Decker, BHP, 3M, Cancer, and Agnico Eagle Mines
-
Centre Daily Times | October 22, 2009
Bristol-Myers posts higher 3Q sales, lower profit
Several Bristol-Myers drugs had double-digit sales jumps. Those included Abilify, Orencia for rheumatoid arthritis, leukemia drug Sprycel and hepatitis B drug Baraclude. The company also launched its newest drug, Onglyza for diabetes,...
In this article: Bristol-Myers, Revenue, Abilify, Bipolar disorder, Baraclude, Sprycel, Plavix, Reyataz, Leukemia, and Orencia
-
Chronic Myelogenous Leukemia (CML)
...with drugs that target the abnormal enzyme responsible for the faulty white blood cells. Imatinib (Gleevec), dasatinib (Sprycel), and nilotinib (Tasigna) shut down the tyrosine kinase enzyme and can keep chronic myelogenous leukemia in...
In this article: Chronic myelogenous leukemia, Kareem Abdul-Jabbar, Philadelphia chromosome, Nilotinib, Leukemia, Tyrosine, Cancer, and Stroke
-
Leukemia Drug May Help Some Ovarian Cancer Patients
...holds promise as a possible treatment for ovarian cancer, new research suggests. The drug dasatinib (Sprycel) is used to treat chronic myeloid leukemia. Researchers at the University of California at Los Angeles report that the drug...
In this article: Ovarian cancer, Leukemia, University of California at Los Angeles, Cancer, Myeloid leukemia, and United States
Trends
Loading...
More on Dasatinib
Description from Wikipedia:
Dasatinib, also known as BMS-354825, is a drug produced by Bristol-Myers Squibb and sold under the trade name Sprycel. Dasatinib is an oral dual BCR/ABL and Src family tyrosine kinases inhibitor approved for use in patients with chronic myelogenous leukemia (CML) after imatinib treatment and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). It is also being assessed for use in metastatic melanoma.
The drug is named after the inventor chemist, Jagabandhu Das, who codiscovered it while working at Bristol Myers Squibb.
Explore everything named Dasatinib...
